Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients

Basem Azab, Neeraj Shah, Jared Radbel, Pamela Tan, Vijaya Bhatt, Steven Vonfrolio, Ayman Habeshy, Antonio Picon, Scott Bloom

Research output: Contribution to journalArticlepeer-review

211 Scopus citations

Fingerprint

Dive into the research topics of 'Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences